Medical News |
- COPD underdiagnosed in nonsmokers
- HSV-1 linked to cognitive deficits in schizophrenia patients
- Children at risk for BD have reduced levels of specific neurometabolites
- Surveillance colonoscopy follow-up system improves adherence
- Being tall and obese significantly increases VTE risk
- Alpha-linolenic acid intake associated with stroke, not CHD
- Indicators of stroke in vertigo patients pinpointed
- Omega-3 linked to aggressive prostate cancer
- Omega-3 linked to aggressive prostate cancer
- E-prescribing may improve attainment of lipid targets
- Alpha-linolenic acid intake associated with stroke, not CHD
- Growth hormone replacement not linked to diabetes in adults
- Insomnia linked to higher glucose and insulin resistance in diabetics
- LANCELOT: atopaxar progresses to phase III testing
- AF costs USA $26 billion each year
| COPD underdiagnosed in nonsmokers Posted: 05 May 2011 05:00 PM PDT Around four-fifths of nonsmokers with moderate or severe chronic obstructive pulmonary disease have not been diagnosed with the lung condition, research suggests. |
| HSV-1 linked to cognitive deficits in schizophrenia patients Posted: 05 May 2011 05:00 PM PDT Exposure to the herpes simplex virus type 1 may contribute to the cognitive deficits in patients with schizophrenia, research suggests. |
| Children at risk for BD have reduced levels of specific neurometabolites Posted: 05 May 2011 05:00 PM PDT The children of parents with bipolar disorder have decreased concentrations of specific metabolites in the cerebellar vermis, suggesting decreased cellular metabolism, US researchers report. |
| Surveillance colonoscopy follow-up system improves adherence Posted: 05 May 2011 05:00 PM PDT A simple follow-up system for increasing the number of patients who attend follow-up surveillance colonoscopy examinations based on endoscopic recommendations has proved successful, US study findings show. |
| Being tall and obese significantly increases VTE risk Posted: 04 May 2011 05:00 PM PDT People who are both tall and obese have a substantially increased risk for venous thromboembolism compared with those who are short and of normal weight, Norwegian researchers report. |
| Alpha-linolenic acid intake associated with stroke, not CHD Posted: 04 May 2011 05:00 PM PDT Alpha-linolenic acid intake is not associated with incident coronary heart disease, study results suggest. |
| Indicators of stroke in vertigo patients pinpointed Posted: 04 May 2011 05:00 PM PDT Physicians should suspect stroke in patients with vertigo if they present with gait instability or subtle neurologic findings, say US researchers. |
| Omega-3 linked to aggressive prostate cancer Posted: 04 May 2011 05:00 PM PDT High levels of omega 3 fatty acids, which are considered beneficial for coronary artery disease prevention, may increase the risk for high-grade prostate cancer, US research shows. |
| Omega-3 linked to aggressive prostate cancer Posted: 04 May 2011 05:00 PM PDT High levels of omega 3 fatty acids, which are considered beneficial for coronary artery disease prevention, may increase the risk for high-grade prostate cancer, US research shows. |
| E-prescribing may improve attainment of lipid targets Posted: 04 May 2011 05:00 PM PDT Results of a US study indicate that electronic prescribing is associated with improved low-density lipoprotein cholesterol goal attainment. |
| Alpha-linolenic acid intake associated with stroke, not CHD Posted: 04 May 2011 05:00 PM PDT Alpha-linolenic acid intake is not associated with incident coronary heart disease, study results suggest. |
| Growth hormone replacement not linked to diabetes in adults Posted: 04 May 2011 05:00 PM PDT Incidence of diabetes in adults taking growth hormone replacement is not significantly higher than that of controls, say researchers. |
| Insomnia linked to higher glucose and insulin resistance in diabetics Posted: 04 May 2011 05:00 PM PDT Diabetic patients who suffer from insomnia have higher glucose levels and a greater degree of insulin resistance than those who do not suffer from sleep disturbances, show study findings. |
| LANCELOT: atopaxar progresses to phase III testing Posted: 04 May 2011 05:00 PM PDT Atopaxar achieves rapid platelet inhibition but may lead to increased bleeding in the treatment of acute coronary syndrome and coronary artery disease patients, US research suggests. |
| AF costs USA $26 billion each year Posted: 04 May 2011 05:00 PM PDT Treating atrial fibrillation and its complications in the USA costs around US $26 billion per year, an economic analysis suggests. |
| You are subscribed to email updates from MedWire Medical News Combined Feed To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
| Google Inc., 20 West Kinzie, Chicago IL USA 60610 | |
No comments:
Post a Comment